Electromed, Inc. Appoints Michael J. MacCourt as Chief Financial Officer
May 18 2020 - 4:30PM
Business Wire
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:
ELMD), a leader in innovative airway clearance technologies, today
announced that its Board of Directors has appointed Michael J.
MacCourt as the Company’s Chief Financial Officer, effective May
26, 2020.
Mr. MacCourt brings to Electromed approximately two decades of
financial leadership and multidimensional business experience
across a range of medical device, consulting and Fortune 500
companies. Prior to his most recent role as Senior Director of
Commercial Finance at Starkey Hearing Technologies, Mr. MacCourt
spent over nine years at Medtronic in roles of increasing
responsibility; concluding as Divisional CFO of the Lung Health
business for the last five years. Mr. MacCourt also has an
extensive consulting background primarily at
PricewaterhouseCoopers, where he held management roles in both
financial process improvement and business analytics. Mr. MacCourt
started his career at Procter & Gamble and then ConAgra Foods,
where he held Financial Analyst, Cost Analyst and Business Analyst
positions.
Kathleen Skarvan, Electromed’s President and CEO, commented, "On
behalf of our Board of Directors and management team, I am
delighted to welcome Mike to Electromed. He is a dynamic financial
executive with a strong track record of building high-performing
teams, solving complex business problems, driving market
development and optimizing the finance function through a
collaborative leadership style. In Mike, we found an incredible
cultural fit. He is a high-energy team player with a keen strategic
mind, complemented by top-notch financial and analytical
acumen.”
Mr. MacCourt added, "I am thrilled to be joining a company that
prioritizes innovation, quality of product and customer service in
delivering its SmartVest® airway clearance devices to patients with
compromised pulmonary function. I look forward to helping the team
drive profitable growth in the years to come.”
Jeremy Brock, Electromed’s current Chief Financial Officer, will
remain with the Company in a supporting role through July 1, 2020
to ensure a smooth CFO transition.
About Electromed, Inc. Electromed manufactures, markets,
and sells products that provide airway clearance therapy, including
the SmartVest® Airway Clearance System, to patients with
compromised pulmonary function. The Company is headquartered in New
Prague, Minnesota and was founded in 1992. Further information
about Electromed can be found at www.smartvest.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200518005603/en/
Electromed, Inc. Kathleen Skarvan, President and Chief Executive
Officer (952) 758-9299 investorrelations@electromed.com The Equity
Group Inc. Kalle Ahl, CFA (212) 836-9614 kahl@equityny.com Devin
Sullivan (212) 836-9608 dsullivan@equityny.com
Electromed (AMEX:ELMD)
Historical Stock Chart
From May 2024 to Jun 2024
Electromed (AMEX:ELMD)
Historical Stock Chart
From Jun 2023 to Jun 2024